Search Results - "Hanjani, P." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study

A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study

by Monk, B.J., Brady, M.F., Aghajanian, C., Lankes, H.A., Rizack, T., Leach, J., Fowler, J.M., Higgins, R., Hanjani, P., Morgan, M., Edwards, R., Bradley, W., Kolevska, T., Foukas, P., Swisher, E.M., Anderson, K.S., Gottardo, R., Bryan, J.K., Newkirk, M., Manjarrez, K.L., Mannel, R.S., Hershberg, R.M., Coukos, G.
Published in Annals of oncology (01.05.2017)

Get full text

Journal Article

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours

by Brana, I, Berger, R, Golan, T, Haluska, P, Edenfield, J, Fiorica, J, Stephenson, J, Martin, L P, Westin, S, Hanjani, P, Jones, M B, Almhanna, K, Wenham, R M, Sullivan, D M, Dalton, W S, Gunchenko, A, Cheng, J D, Siu, L L, Gray, J E
Published in British journal of cancer (11.11.2014)

Get full text

Journal Article

A phase II, randomized, double-blind, placebo-controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: A Gynecologic Oncology Group partners study

A phase II, randomized, double-blind, placebo-controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: A Gynecologic Oncology Group partners study

by Monk, B.J, Brady, M.F, Aghajanian, C, Lankes, H, Rizack, T, Leach, J.W, Fowler, J.M, Higgins, R.V, Hanjani, P, Morgan, M.A
Published in Gynecologic oncology (01.06.2017)

Get full text

Journal Article

Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study

Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study

by Rose, P.G, Java, J, Morgan, M.A, Secord, A.A, Kesterson, J, Stehman, F.B, Warshal, D.P, Creasman, W.T, Hanjani, P, Morris, R.T, Copeland, L.J
Published in Gynecologic oncology (01.06.2016)

Get full text

Journal Article

A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: A Gynecologic Oncology Group study

A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: A Gynecologic Oncology Group study

by Schilder, R.J, Sill, M.W, Lankes, H.A, Gold, M.A, Mannel, R.S, Modesitt, S.C, Hanjani, P, Bonebrake, A.J, Sood, A.K, Godwin, A.K, Hu, W, Alpaugh, R.K
Published in Gynecologic oncology (01.04.2013)

Get full text

Journal Article

Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group

Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group

by Williams, S, Blessing, J A, Liao, S Y, Ball, H, Hanjani, P
Published in Journal of clinical oncology (01.04.1994)

Get more information

Journal Article

Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study

Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study

by Markman, M, Brady, M F, Spirtos, N M, Hanjani, P, Rubin, S C
Published in Journal of clinical oncology (01.08.1998)

Get more information

Journal Article

Successful treatment of two patients with gestational trophoblastic neoplasm presenting with emergent neurologic symptoms

Successful treatment of two patients with gestational trophoblastic neoplasm presenting with emergent neurologic symptoms

by Ghaemmaghami, F, Behtash, N, Ayatollahi, H, Hanjani, P
Published in International journal of gynecological cancer (01.03.2006)

Get more information

Journal Article

Oral Topotecan as Single-Agent Second-Line Chemotherapy in Patients With Advanced Ovarian Cancer

Oral Topotecan as Single-Agent Second-Line Chemotherapy in Patients With Advanced Ovarian Cancer

by CLARKE-PEARSON, D. L, VAN LE, L, DEWITTE, Mark H, FIELDS, S. Z, IVESON, T, WHITNEY, C. W, HANJANI, P, KRISTENSEN, G, MALFETANO, J. H, BECKMAN, R. A, ROSS, G. A, LANE, S. R
Published in Journal of clinical oncology (01.10.2001)

Get full text

Journal Article

Successful treatment of two patients with gestational trophoblastic neoplasm presenting with emergent neurologic symptoms

Successful treatment of two patients with gestational trophoblastic neoplasm presenting with emergent neurologic symptoms

by Ghaemmaghami, F, Behtash, N, Ayatollahi, H, Hanjani, P
Published in International journal of gynecological cancer (01.03.2006)

Get full text

Journal Article

EMA‐EP regimen, as firstline multiple agent chemotherapy in high‐risk GTT patients (stage II–IV)

EMA‐EP regimen, as firstline multiple agent chemotherapy in high‐risk GTT patients (stage II–IV)

by Ghaemmaghami, F., Modares, M., Arab, M., Behtash, N., Moosavi, A. Z., Khanafshar, N., Hanjani, P.
Published in International journal of gynecological cancer (01.03.2004)

Get full text

Journal Article

Evaluation and management of brain metastatic patients with high‐risk gestational trophoblastic tumors

Evaluation and management of brain metastatic patients with high‐risk gestational trophoblastic tumors

by Ghaemmaghami, F., Behtash, N., Memarpour, N., Soleimani, K., Hanjani, P., Hashemi, F. A.
Published in International journal of gynecological cancer (01.09.2004)

Get full text

Journal Article

Telephone counseling improves adherence to colposcopy among lower-income minority women

Telephone counseling improves adherence to colposcopy among lower-income minority women

by Lerman, C, Hanjani, P, Caputo, C, Miller, S, Delmoor, E, Nolte, S, Engstrom, P
Published in Journal of clinical oncology (01.02.1992)

Get more information

Journal Article

Simple hysterectomy in the presence of invasive cervical cancer in Iran

Simple hysterectomy in the presence of invasive cervical cancer in Iran

by Behtash, N., Mousavi, A., Mohit, M., Modares, M., Khanafshar, N., Hanjani, P.
Published in International journal of gynecological cancer (01.03.2003)

Get full text

Journal Article

Borderline ovarian tumours: clinical analysis of 38 cases

Borderline ovarian tumours: clinical analysis of 38 cases

by Behtash, N, Modares, M, Abolhasani, M, Ghaemmaghami, F, Mousavi, M, Yarandi, F, Hanjani, P
Published in Journal of obstetrics and gynaecology (01.02.2004)

Get more information

Journal Article

Evaluation and management of brain metastatic patients with high-risk gestational trophoblastic tumors

Evaluation and management of brain metastatic patients with high-risk gestational trophoblastic tumors

by Ghaemmaghami, F., Behtash, N., Memarpour, N., Soleimani, K., Hanjani, P., Hashemi, F. A.
Published in International journal of gynecological cancer (01.08.2004)

Get full text

Journal Article

EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II–IV)

EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II–IV)

by Ghaemmaghami, F., Modares, M., Arab, M., Behtash, N., Moosavi, A. Z., Khanafshar, N., Hanjani, P.
Published in International journal of gynecological cancer (01.02.2004)

Get full text

Journal Article

Simple hysterectomy in the presence of invasive cervical cancer in Iran

Simple hysterectomy in the presence of invasive cervical cancer in Iran

by Behtash, N., Mousavi, A., Mohit, M., Modares, M., Khanafshar, N., Hanjani, P.
Published in International journal of gynecological cancer (01.02.2003)

Get full text

Journal Article

Uterine papillary serous carcinoma after pelvic radiation therapy for cancer of the cervix

Uterine papillary serous carcinoma after pelvic radiation therapy for cancer of the cervix

by Behtash, N, Tehranian, A, Ardalan, F A, Hanjani, P
Published in Journal of obstetrics and gynaecology (01.01.2002)

Get more information

Journal Article

A randomized phase II/III study to assess the efficacy of trametinib in patients with recurrent or progressive low-grade serous ovarian or peritoneal cancer

A randomized phase II/III study to assess the efficacy of trametinib in patients with recurrent or progressive low-grade serous ovarian or peritoneal cancer

by Gershenson, D.M., Miller, A., Brady, W., Paul, J., Carty, K., Rodgers, W., Millan, D., Coleman, R.L., Moore, K.N., Banerjee, S., Connolly, K., Secord, A.A., O’Malley, D.M., Dorigo, O., Gaillard, S., Gabra, H., Hanjani, P., Huang, H., Wenzel, L., Gourley, C.
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article